Carol J. Fabian

Carol J. Fabian

Oncology
2650 Shawnee Mission Parkway
Westwood, KS 66205

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications

Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity.

Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity.

Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026

Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk.

Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: January 21, 2026

Circulating tumor cells as predictive biomarkers in the risk stratification of DCIS: Evidence of early dissemination.

Circulating tumor cells as predictive biomarkers in the risk stratification of DCIS: Evidence of early dissemination.

Journal: Science advances
Published: October 29, 2025

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Journal: Ecancermedicalscience
Published: August 25, 2025

RISE UP for breast cancer 2024: conference highlights & takeaways.

RISE UP for breast cancer 2024: conference highlights & takeaways.

Journal: Breast cancer research and treatment
Published: August 20, 2025

Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk.

Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk.

Journal: JCI insight
Published: June 14, 2024

Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.

Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.

Journal: Contemporary clinical trials
Published: June 10, 2024

Reduced-Frequency Endocrine Therapy and Challenges of Noninferiority Study Designs.

Reduced-Frequency Endocrine Therapy and Challenges of Noninferiority Study Designs.

Journal: JAMA oncology
Published: March 23, 2023

Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer.

Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer.

Journal: CA: a cancer journal for clinicians
Published: October 25, 2022

A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer.

A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer.

Journal: Trials
Published: March 23, 2022

Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors.

Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors.

Journal: Cancers
Published: August 31, 2021

Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?

Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 15, 2021
Showing 1-12 of 115

Last Updated: 09/26/2026